BCL2 and hepatocellular carcinoma: Compound-protein interaction network analysis showed that emblicanin A, penta-o-galloylglucose, punigluconin and quercetin can target multiple proteins such as EGFR, FGFR1, BCL2 and Hsp90 mainly involved in HCC.